SEMIZLIK VA METABOLIK SINDROMDA BIOIMPEDANS ANALIZATORINI O’RGANISH VA NATIJALARNI TAHLIL QILISH
;
Semizlik, metabolik, sindromiAbstrak
Semizlik bilan kasallangan bemorlarning tana vazn indexiga baho berish. Bioimpedans analizatori orqali semiz va metabolik sindromi bor bemorlarni tekshirib, ko`rsatkichlar ustida ishlash va solishtirish. Metobolik sindromning belgilari o’zgarishini tahlil qilish. Semizlikka turmush tarzini qay darajada ahamiyatli ekanini o`rganish. Sog`lom ovqatlanish va faol hayot tarzini shu bemorlarda qo`llab natijalarni solishtirish.
Iqtiboslar
Fenske W, Allolio B. Clinical review: Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J Clin Endocrinol Metab. 2012 Oct;97(10):3426-37. [PubMed]
Grace M, Balachandran V, Preethy. Menon S. Idiopathic central diabetes Insipidus. Indian J Med Sci. 2011 Oct;65(10):452-5. [PubMed]
Kalra S, Zargar AH, Jain SM, Sethi B, Chowdhury S, Singh AK, Thomas N, Unnikrishnan AG, Thakkar PB, Malve H. Diabetes insipidus: The other diabetes. Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):9-21. [PMC free article] [PubMed]
Kimmel DW, O'Neill BP. Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastaticinduced diabetes insipidus. Cancer. 1983 Dec 15;52(12):2355-8. [PubMed]
Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, Tinelli C, Gallucci M, Bernasconi S, Boscherini B, Severi F, Aricò M. Central diabetes insipidus in children and young adults. N Engl J Med. 2000 Oct 05;343(14):9981007. [PubMed]
Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H. Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med. 1993 Sep 02;329(10):683-9. [PubMed]
De Bellis A, Colao A, Di Salle F, Muccitelli VI, Iorio S, Perrino S, Pivonello R, Coronella C, Bizzarro A, Lombardi G, Bellastella A. A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus. J Clin Endocrinol Metab. 1999 Sep;84(9):3047-51. [PubMed]
Pivonello R, De Bellis A, Faggiano A, Di Salle F, Petretta M, Di Somma C, Perrino S, Altucci P, Bizzarro A, Bellastella A, Lombardi G, Colao A. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab. 2003 Apr;88(4):1629-36. [PubMed]
Iwama S, Sugimura Y, Kiyota A, Kato T, Enomoto A, Suzuki H, Iwata N, Takeuchi S, Nakashima K, Takagi H, Izumida H, Ochiai H, Fujisawa H, Suga H, Arima H,Shimoyama Y, Takahashi M, Nishioka H, Ishikawa SE, Shimatsu A, Caturegli P, Oiso Y. Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis. J Clin Endocrinol Metab. 2015 Jul;100(7):E94654. [PMC free article] [PubMed]
Johnston PC, Chew LS, Hamrahian AH, Kennedy L. Lymphocytic infundibulo-neurohypophysitis: a clinical overview. Endocrine. 2015 Dec;50(3):531-6. [PubMed]
Christensen JH, Rittig S. Familial neurohypophyseal diabetes insipidus-an update. Semin Nephrol. 2006 May;26(3):209-23. [PubMed]
